ABSTRACT
Background: Infertility, defined as failure to achieve pregnancy after one year of regular unprotected intercourse, is a significant reproductive health problem in sub-Saharan Africa. In Nigeria, tubal damage caused by infections, most especially byNeisseria gonorrhoeae andChlamydia
trachomatis, accounts for a substantial proportion of cases. This study assessed the role ofC. trachomatis infection in female infertility at a tertiary centre in south-western Nigeria.
Methods: A case-control study was conducted at the then Ladoke Akintola University of Technology Teaching Hospital (LAUTECH), Osogbo, now renamed UNIOSUN Teaching Hospital (UNIOSUNTH), Osogbo. Thirty six women presenting with infertility (cases) and 38 healthy pregnant women (controls) of reproductive age (15–49 years) were enrolled. Chlamydia trachomatis IgG antibodies were detected using the
ImmunoComb semi-quantitative ELISA kit; titres e” 1:32 were considered positive. Hysterosalpingography (HSG) was performed in all cases to assess tubal patency.
Results: Chlamydia IgG antibodies were detected in 20 (55.6%) infertile women compared with 5 (13.2%) fertile controls (÷² = 14.86, p < 0.001). Bilateral tubal occlusion on HSG was found in 15 (93.8%) Chlamydia seropositive infertile women versus 5 (25.0%) seronegative cases (÷² = 17.016, p < 0.001). Using tubal occlusion as the reference standard, Chlamydia IgG serology demonstrated a sensitivity of 93.8%, specificity of 75.0%, and positive and negative predictive values of 75.0% and 93.8%, respectively.
Conclusion:Chlamydia trachomatis IgG antibody detection by ELISA is a useful, rapid, and non-invasive test. It does not replace HSG but may serve as a practical adjunct and triage tool to identify infertile women who should be prioritised for HSG assessment of tubal factor infertility, particularly in resource-limited settings.
Keywords:Chlamydia trachomatis, female infertility, IgG antibodies, tubal occlusion, hysterosalpingography, Nigeria